New England Journal of Medicine Perspective Pieces Examine OTC Status for Statins, the Future of Specialty Hospitals

Main Category: Statins
Article Date: 11 Apr 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated

.
"Statins and Over-the-Counter Availability," New England Journal of Medicine: It is "relatively easy to see why an FDA advisory committee ... recently recommended against" granting statins over-the-counter status because the medications "fail to meet many of the ... criteria for a switch to over-the-counter status," Brian Strom, a professor of biostatistics and epidemiology at the University of Pennsylvania School of Medicine, writes in a perspective piece. According to Strom, while it is true that moving statins over the counter would "increase access to an effective and underused therapy," a number of considerations -- including the fact that high cholesterol is not self-diagnosable and statins' safety in special populations is "uncertain" -- "suggest that they would make poor over-the-counter drugs" (Strom, New England Journal of Medicine, 4/7).


"The Uncertain Future of Specialty Hospitals," New England Journal of Medicine: John Iglehart, a correspondent for NEJM, examines whether Congress will decide to extend the federal moratorium on new specialty hospitals or enact new policies that allow the construction of new facilities and "thus encourage a form of competition ... that general hospitals regard as unfair." Noting that the Medicare Payment Advisory Commission has recommended extending the moratorium past June 8, Iglehart writes that the Republican-controlled Congress' decision "will indicate the extent of that party's willingness to promote market-based solutions," since many Democrats and officials in the general hospital community believe specialty hospitals should be "strictly limited, if not prohibited, by the government" (Iglehart, New England Journal of Medicine, 4/7).

"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our statins section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "New England Journal of Medicine Perspective Pieces Examine OTC Status for Statins, the Future of Specialty Hospitals." Medical News Today. MediLexicon, Intl., 11 Apr. 2005. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/22627.php>

APA
Christian Nordqvist. (2005, April 11). "New England Journal of Medicine Perspective Pieces Examine OTC Status for Statins, the Future of Specialty Hospitals." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/22627.php.

Please note: If no author information is provided, the source is cited instead.


Statins

What are Statins?

Statins are a class of medicines that are frequently used to lower blood cholesterol levels. The drugs are able to block the action of a chemical in the liver that is necessary for making cholesterol. Read more...

Most Popular Articles



Follow Our Statins News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Statins Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »